COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma (2018)
Source: Pathology, Research and Practice. Unidade: FO
Subjects: AMELOBLASTOMA, TUMORES ODONTOGÊNICOS
ABNT
MONTEZUMA, Marco Aurélio Petron et al. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma. Pathology, Research and Practice, v. 214, p. 907-913, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.prp.2018.03.014. Acesso em: 05 out. 2024.APA
Montezuma, M. A. P., Fonseca, F. P., Benitesa, B. M., Soares, C. D., Silva, G. K. do A., Almeida, O. P. de, et al. (2018). COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma. Pathology, Research and Practice, 214, 907-913. doi:10.1016/j.prp.2018.03.014NLM
Montezuma MAP, Fonseca FP, Benitesa BM, Soares CD, Silva GK do A, Almeida OP de, Soares FA, Pagano RL, Fregnani ER. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma [Internet]. Pathology, Research and Practice. 2018 ; 214 907-913.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.prp.2018.03.014Vancouver
Montezuma MAP, Fonseca FP, Benitesa BM, Soares CD, Silva GK do A, Almeida OP de, Soares FA, Pagano RL, Fregnani ER. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma [Internet]. Pathology, Research and Practice. 2018 ; 214 907-913.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.prp.2018.03.014